Correlation Between Kinnate Biopharma and Ambrx Biopharma
Can any of the company-specific risk be diversified away by investing in both Kinnate Biopharma and Ambrx Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kinnate Biopharma and Ambrx Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kinnate Biopharma and Ambrx Biopharma American, you can compare the effects of market volatilities on Kinnate Biopharma and Ambrx Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kinnate Biopharma with a short position of Ambrx Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kinnate Biopharma and Ambrx Biopharma.
Diversification Opportunities for Kinnate Biopharma and Ambrx Biopharma
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Kinnate and Ambrx is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Kinnate Biopharma and Ambrx Biopharma American in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ambrx Biopharma American and Kinnate Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kinnate Biopharma are associated (or correlated) with Ambrx Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ambrx Biopharma American has no effect on the direction of Kinnate Biopharma i.e., Kinnate Biopharma and Ambrx Biopharma go up and down completely randomly.
Pair Corralation between Kinnate Biopharma and Ambrx Biopharma
If you would invest 1,573 in Ambrx Biopharma American on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Ambrx Biopharma American or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kinnate Biopharma vs. Ambrx Biopharma American
Performance |
| Timeline |
| Kinnate Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Ambrx Biopharma American |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kinnate Biopharma and Ambrx Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kinnate Biopharma and Ambrx Biopharma
The main advantage of trading using opposite Kinnate Biopharma and Ambrx Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kinnate Biopharma position performs unexpectedly, Ambrx Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambrx Biopharma will offset losses from the drop in Ambrx Biopharma's long position.| Kinnate Biopharma vs. ACELYRIN, INC Common | Kinnate Biopharma vs. Windtree Therapeutics | Kinnate Biopharma vs. Palisade Bio | Kinnate Biopharma vs. Century Therapeutics |
| Ambrx Biopharma vs. Immix Biopharma | Ambrx Biopharma vs. Cns Pharmaceuticals | Ambrx Biopharma vs. Sonnet Biotherapeutics Holdings | Ambrx Biopharma vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |